human
respiratori
syncyti
viru
hrsv
lead
caus
sever
acut
lower
respiratori
tract
infect
alrti
human
age
main
caus
hospit
due
pneumonia
asthma
bronchiol
infant
hrsv
symptom
mainli
develop
due
excess
host
immun
inflammatori
respons
respiratori
tissu
hrsv
infect
life
frequent
like
nonoptim
immunolog
memori
develop
viru
vaccin
develop
pathogen
delay
detriment
effect
produc
children
vaccin
formalininactiv
hrsv
prepar
fihrsv
caus
enhanc
diseas
upon
natur
viral
infect
sinc
sever
studi
focus
understand
mechan
underli
diseas
exacerb
along
line
sever
studi
suggest
antibodi
elicit
immun
fihrsv
show
low
neutral
capac
promot
format
immun
complex
contain
hrsv
hrsvic
contribut
hrsv
pathogenesi
engag
fc
gamma
receptor
express
surfac
immun
cell
furthermor
role
support
studi
evalu
contribut
molecul
hrsvinduc
diseas
studi
shown
modul
viral
clearanc
host
inflammatori
respons
trigger
hrsv
infect
addit
ic
facilit
viral
entri
host
cell
express
thu
extend
hrsv
infect
articl
discuss
current
knowledg
rel
contribut
hrsvic
pathogenesi
caus
hrsv
put
role
exacerb
diseas
caus
viru
fihrsv
vaccin
better
understand
involv
immun
respons
hrsv
contribut
develop
new
prophylact
therapeut
tool
promot
viru
clearanc
limit
inflammatori
damag
airway
human
respiratori
syncyti
viru
hrsv
lead
caus
sever
acut
lower
respiratori
tract
infect
alrti
human
age
main
caus
hospit
due
pneumonia
asthma
bronchiol
infant
hrsv
symptom
mainli
develop
due
excess
host
immun
inflammatori
respons
respiratori
tissu
hrsv
infect
life
frequent
like
nonoptim
immunolog
memori
develop
viru
vaccin
develop
pathogen
delay
detriment
effect
produc
children
vaccin
formalininactiv
hrsv
prepar
fihrsv
caus
enhanc
diseas
upon
natur
viral
infect
sinc
sever
studi
focus
understand
mechan
underli
diseas
exacerb
along
line
sever
studi
suggest
antibodi
elicit
immun
fihrsv
show
low
neutral
capac
promot
format
immun
complex
contain
hrsv
hrsvic
contribut
hrsv
pathogenesi
engag
fc
gamma
receptor
express
surfac
immun
cell
furthermor
role
support
studi
evalu
contribut
molecul
hrsvinduc
diseas
studi
shown
modul
viral
clearanc
host
inflammatori
respons
trigger
hrsv
infect
addit
ic
facilit
viral
entri
host
cell
express
thu
extend
hrsv
infect
articl
discuss
current
knowledg
rel
contribut
hrsvic
pathogenesi
caus
hrsv
put
role
exacerb
diseas
caus
viru
fihrsv
vaccin
better
understand
involv
immun
respons
hrsv
contribut
develop
new
prophylact
therapeut
tool
promot
viru
clearanc
limit
inflammatori
damag
airway
human
respiratori
syncyti
viru
hrsv
singlestrand
rna
envelop
viru
belong
pneumovirida
famili
amarasingh
et
al
viral
particl
filament
structur
consist
nucleocapsid
surround
lipid
bilay
envelop
obtain
plasma
membran
host
cell
el
omari
et
al
importantli
infect
hrsv
frequent
caus
sever
acut
lower
respiratori
tract
infect
alrti
children
younger
year
old
scheltema
et
al
infect
first
year
life
main
caus
hospit
infant
song
et
al
accord
epidemiolog
studi
past
decad
nearli
million
case
new
alrti
episod
affect
children
first
month
life
due
hrsv
infect
year
shi
et
al
therefor
infect
viru
repres
major
health
socioeconom
burden
worldwid
diezdomingo
et
al
amand
et
al
clinic
manifest
caus
hrsv
infect
rang
mild
symptom
rhiniti
sever
consequ
includ
bronchiol
pneumonia
pickl
devincenzo
besid
extrapulmonari
manifest
hrsv
infect
also
report
occur
acut
neurolog
symptom
seizur
ataxia
observ
hrsvinfect
children
eisenhut
bohmwald
et
al
longterm
behavior
cognit
impair
anim
model
espinoza
et
al
remark
known
children
becom
infect
hrsv
first
year
life
domachowsk
rosenberg
like
hrsv
effici
pass
one
individu
anoth
also
capac
viru
neg
modul
cell
b
cell
respons
upon
infect
allow
frequent
reinfect
prabhuda
et
al
cesped
et
al
zhivaki
et
al
featur
thought
mediat
host
viral
factor
instanc
known
infant
show
reduc
capac
produc
neutral
antibodi
hrsv
compar
adult
make
former
suscept
recurr
infect
siegrist
aspinal
although
maternallydeliv
antibodi
matab
report
delay
onset
primari
hrsv
infect
presenc
blood
infant
associ
develop
less
sever
diseas
symptom
jan
et
al
observ
suggest
antibodymedi
neutral
hrsv
may
suffici
limit
hrsv
infect
diseas
sever
furthermor
hrsv
encod
sever
protein
abil
neg
modul
impair
host
antivir
immun
respons
therefor
contribut
reinfect
mason
et
al
cesped
et
al
saint
et
al
bohmwald
et
al
gomez
et
al
canedomarroquin
et
al
ward
et
al
knowledg
relev
design
novel
vaccin
therapeut
approach
prevent
patholog
caus
hrsv
result
sever
clinic
trial
current
progress
assess
safeti
effect
differ
hrsv
vaccin
candid
cautivo
et
al
reyjurado
kalergi
rezae
et
al
among
develop
uniqu
approach
administ
newborn
young
infant
immun
mous
model
recombin
bacillu
bcg
express
nucleoprotein
n
hrsv
rbcgnhrsv
induc
product
neutral
antibodi
hrsv
helper
cellular
immun
protect
hrsv
associatedlung
patholog
decreas
infiltr
inflammatori
immun
cell
lung
reduc
viral
load
airway
hrsvinfect
mice
bueno
et
al
cautivo
et
al
leyrat
et
al
furthermor
singl
low
dose
vaccin
produc
use
current
good
manufactur
practic
cgmp
confer
protect
hrsv
infect
mous
model
cesped
et
al
given
result
recombinantbas
vaccin
aris
promis
candid
prevent
lung
damag
caus
viru
cesped
et
al
context
possibl
mechan
contribut
prevent
hrsv
patholog
follow
rbcgnhrsv
vaccin
induct
antibodi
recogn
hrsv
n
protein
necessari
viral
replic
inhibit
immunolog
synaps
dc
cell
promot
tcell
activ
cesped
et
al
therefor
hrsv
n
protein
becom
neutral
antibodi
infect
contribut
viral
replic
also
fail
abil
impair
format
dc
cell
thu
hamper
proper
immun
respons
hrsv
furthermor
recent
public
group
show
immun
rbcgnhrsv
induc
product
antibodi
hrsv
protein
f
g
serv
neutral
infect
therefor
reduc
hrsv
associ
patholog
soto
et
al
contrast
vaccin
candid
group
use
f
protein
target
antigen
confer
immun
exampl
novavax
inc
current
perform
clinic
trial
base
use
nanoparticl
link
hrsv
f
protein
induc
product
neutral
antibodi
hrsv
mazur
et
al
similarli
janssen
current
test
adenoviru
base
vector
vaccin
encod
prefus
form
hrsv
f
protein
also
induc
product
antihrsv
neutral
antibodi
mazur
et
al
final
live
attenu
vaccin
case
rbcgnhrsv
base
attenu
hrsv
lack
particular
protein
mazur
et
al
togeth
data
indic
vital
import
delin
mechan
contribut
hrsv
induc
patholog
order
prevent
treat
infect
latter
point
recurr
hrsv
reinfect
episod
common
thorough
life
encourag
gener
studi
seek
defin
mechan
respons
consid
impair
nonoptim
immun
respons
elicit
hrsv
upon
infect
account
reinfect
episod
openshaw
chiu
cesped
et
al
shao
et
al
along
line
role
interact
immun
complex
consist
igg
hrsv
ic
fc
gamma
receptor
could
process
contribut
reinfect
episod
enhanc
hrsvdiseas
elicit
vaccin
formalininactiv
hrsv
fihrsv
later
hrsv
natur
infect
kim
et
al
hypothesi
support
fact
high
amount
antibodi
low
neutral
activ
induc
immun
fihrsv
correl
enhanc
hrsvinduc
diseas
kapikian
et
al
kim
et
al
therefor
possibl
low
affin
antibodi
promot
infect
cell
phenomena
call
antibodi
depend
enhanc
ade
previous
observ
virus
yip
et
al
gu
et
al
flips
et
al
furthermor
vitro
vivo
studi
shown
blockad
absenc
particular
express
surfac
immun
cell
modul
immun
respons
viru
onset
hrsvinduc
diseas
osiowi
et
al
kruijsen
et
al
gomez
et
al
van
erp
et
al
articl
review
discuss
current
understand
contribut
infect
modul
immun
respons
hrsv
vitro
vivo
impact
hrsvinduc
patholog
fcgamma
receptor
bind
immunoglobulin
g
igg
antibodi
ab
recogn
fc
region
igg
promot
receptor
cluster
cell
surfac
phosphoryl
tyrosin
residu
present
signal
motif
within
intracellular
region
receptor
engag
ultim
lead
signal
cascad
cell
result
express
surfac
molecul
secret
solubl
mediat
modul
host
immun
respons
getahun
cambier
renner
et
al
soto
et
al
importantli
type
receptor
express
surfac
immun
cell
neutrophil
dendrit
cell
dc
macrophag
among
other
zhang
et
al
gener
classic
member
famili
protein
classifi
accord
immunemodulatori
properti
either
promot
inhibit
inflammatori
respons
nimmerjahn
ravetch
guilliam
et
al
howev
also
classifi
typei
typeii
base
capac
interact
two
open
close
conform
state
igg
fc
domain
banega
banega
et
al
typei
includ
classic
engag
igg
fc
domain
open
conform
state
banega
banega
et
al
contrast
typeii
noncanon
includ
ctype
lectin
receptor
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
preferenti
bind
igg
fc
close
conform
banega
banega
et
al
human
socal
classic
known
tabl
tripp
et
al
guilliam
et
al
among
studi
perform
indic
express
increas
natur
killer
cell
nk
cell
patient
sever
hrsv
associ
patholog
thu
suggest
receptor
particular
cell
popul
could
contribut
hrsv
diseas
tabl
tripp
et
al
nevertheless
two
nonclass
human
fcgamma
receptor
neonat
fcreceptor
fcrn
cytosol
tripartit
motif
trim
bind
igg
intern
cell
guilliam
et
al
howev
studi
contribut
hrsv
induc
patholog
hrsv
posit
patient
tabl
importantli
canon
except
involv
activ
function
phagocytosi
antibodydepend
cellular
cytotox
adcc
releas
inflammatori
cytokin
follow
iggopson
complex
guilliam
et
al
activ
process
reli
srcfamili
kinasemedi
phosphoryl
immunoreceptor
tyrosinebas
activ
motif
itam
locat
cytoplasm
portion
activ
fcreceptor
nimmerjahn
ravetch
subsequ
phosphoinositid
activ
gener
phosphatidylinositol
trisphosph
lead
recruit
bruton
tyrosin
kinas
btk
activ
phospholipas
promot
releas
calcium
ca
endoplasm
reticulum
er
turn
activ
cell
effector
function
nimmerjahn
ravetch
contrast
abl
termin
activ
cascad
associ
engag
activ
malbec
et
al
also
known
inhibitori
process
becom
engag
ic
coaggreg
activ
receptor
follow
differ
recruit
kinas
phosphoryl
conserv
tyrosin
within
immunoreceptor
tyrosinebas
inhibitori
motif
itim
locat
cytoplasm
tail
malbec
et
al
phosphoryl
step
lead
recruit
tyrosin
phosphatas
well
inositol
phosphatas
suppress
activ
signal
deriv
activ
dambrosio
et
al
ono
et
al
mous
four
differ
canon
express
cell
surfac
tabl
nimmerjahn
ravetch
among
activ
wherea
one
inhibitori
interest
proinflammatori
role
receptor
report
hrsv
infect
mous
model
wherea
inhibitori
shown
hamper
inflammatori
reaction
allergiclik
rhiniti
malbec
et
al
allerg
asthma
dambrosio
et
al
hrsv
infect
therefor
receptor
appear
attract
target
novel
therapeut
approach
kind
diseas
base
anim
studi
neutrophil
describ
promot
inflamm
tissu
damag
hrsv
infect
yasui
et
al
addit
studi
mice
evalu
role
lung
damag
produc
neutrophil
model
acut
lung
injuri
ali
resembl
caus
hrsv
infect
suggest
anim
lack
activ
mice
protect
ali
trigger
administr
igg
mab
recogn
selfantigen
mhci
molecul
looney
et
al
support
role
neutrophil
activ
model
lung
injuri
studi
show
ali
observ
mice
adopt
transfer
wildtyp
neutrophil
follow
administr
antimhci
mab
looney
et
al
taken
togeth
result
suggest
lung
diseas
model
depend
express
activ
neutrophil
case
hrsv
infect
shown
recruit
neutrophil
lung
infect
mice
modul
presenc
differ
figur
instanc
report
anim
lack
activ
show
decreas
neutrophil
recruit
higher
viral
load
suggest
could
play
proinflammatori
role
hrsv
primari
infect
promot
viral
clearanc
consist
result
describ
mice
lack
inhibitori
show
increas
neutrophil
infiltr
lung
due
hrsv
infect
decreas
viral
load
thu
suggest
receptor
play
antiinflammatori
role
hrsvinduc
diseas
despit
contribut
viral
replic
vitro
studi
use
human
neutrophil
show
hrsvic
establish
hrsv
antihrsv
autolog
serum
free
hrsv
antibodi
alon
could
promot
releas
reactiv
oxygen
speci
ro
neutrophil
could
contribut
lung
tissu
damag
figur
kaul
et
al
winterbourn
et
al
therefor
possibl
activ
neutrophil
mediat
engag
like
occur
physiolog
condit
individu
becom
infect
notion
support
studi
show
increas
releas
human
neutrophil
challeng
opson
hrsv
arnold
et
al
cytokin
relev
describ
secret
work
chemotact
signal
neutrophil
induc
activ
lead
proinflammatori
respons
henkel
et
al
vitro
evid
suggest
engag
activ
neutrophil
therefor
contribut
lung
inflamm
progress
hrsv
diseas
figur
dendrit
cell
dc
modul
immun
respons
viral
infect
captur
ic
either
activ
inhibitori
guilliam
et
al
along
line
iggantigen
complex
trigger
activ
signal
human
dc
hdc
bind
promot
inflammatori
respons
bandukwala
et
al
contrast
bind
ic
inhibitori
trigger
inhibit
signal
lead
reduc
inflamm
boruchov
et
al
addit
describ
hrsvic
contain
either
neutral
nonneutr
antibodi
modul
dc
function
subsequ
cell
respons
elicit
antigen
present
cell
kruijsen
et
al
gomez
et
al
context
hrsv
infect
report
dcmediat
cell
activ
product
cell
modul
presenc
activ
dc
surfac
kruijsen
et
al
case
observ
dc
deriv
wt
adult
mice
abl
induc
product
cell
presenc
antihrsv
immun
serum
obtain
mice
challeng
hrsv
kruijsen
et
al
nevertheless
observ
increas
respons
cell
reduc
dc
deriv
mice
therefor
express
activ
dc
surfac
requir
promot
product
cytokin
cell
remark
unalt
secret
cell
observ
dc
deriv
mice
compar
wt
mice
kruijsen
et
al
indic
dcmediat
stimul
secret
cell
depend
presenc
inhibitori
kruijsen
et
al
interestingli
anoth
report
indic
cell
repres
import
sourc
neonat
hrsv
infect
murin
model
requir
prevent
reinfect
diseas
sever
adult
mice
lee
et
al
figur
put
mechan
explain
hrsvinduc
inflamm
due
hrsvic
interact
fcgamma
receptor
express
surfac
neutrophil
primari
infect
hrsv
induc
secret
proinflammatori
cytokin
chemokin
promot
neutrophil
recruit
lung
airway
infect
hrsv
phagocyt
dc
impair
matur
infect
dc
migrat
lymph
node
fail
activ
cell
poorli
understood
mechan
cell
fail
help
b
cell
promot
prolifer
plasma
cell
produc
antihrsv
antibodi
low
neutral
capac
serum
antibodi
produc
primari
hrsv
infect
opson
hrsv
secondari
infect
opson
hrsv
phagocyt
neutrophil
infect
cell
trigger
releas
cytokin
promot
activ
recruit
neutrophil
activ
neutrophil
releas
metabol
product
ie
reactiv
oxygen
speci
ro
promot
lung
damag
inflamm
thu
possibl
activ
contribut
prevent
reinfect
adulthood
promot
product
cell
dcmediat
antigen
present
howev
necessari
determin
whether
activ
dc
surfac
also
modul
product
cytokin
neonat
tcell
prevent
reinfect
recent
studi
shown
anoth
igg
fc
receptor
particularli
neonat
fc
receptor
igg
fcrn
nonclass
fc
receptor
bind
igg
acid
ph
qiao
et
al
contribut
activ
cell
dc
load
hrsvic
kruijsen
et
al
moreov
bone
marrowderiv
dc
bmdc
mice
exhibit
unalt
capac
induc
product
tcell
kruijsen
et
al
result
valid
vivo
mice
also
display
unalt
product
tcell
intranas
challeng
hrsvic
kruijsen
et
al
result
group
indic
bmdc
display
reduc
capac
induc
product
cell
load
hrsvic
neutral
antibodi
palivizumab
synagi
tm
contrast
assay
perform
bmdc
deriv
either
mice
secret
cell
restor
result
prompt
present
receptor
impair
capac
dc
induc
secret
cell
note
product
cytokin
requir
gener
memori
regulatori
cell
treg
perform
antiinflammatori
function
hrsv
infect
protect
reinfect
durant
et
al
thu
possibl
contribut
hrsv
pathogenesi
reinfect
impair
capac
dc
promot
product
cell
human
presenc
two
type
recogn
banega
banega
et
al
typei
member
immunoglobulin
superfamili
either
activ
inhibitori
ravetch
contrast
typeii
member
ctype
lectin
receptor
famili
compris
two
differ
member
ige
receptor
surfac
protein
dcsign
banega
banega
et
al
miettinen
abl
recogn
fc
portion
igg
kaneko
et
al
svajger
et
al
also
g
protein
express
hrsv
johnson
et
al
interest
studi
evalu
role
dcsign
hdc
hrsv
infect
show
blockad
receptor
specif
mab
led
increas
express
matur
marker
follow
hrsv
infect
johnson
et
al
suggest
interact
hrsv
surfac
protein
dcsign
suppress
aspect
dc
activ
human
thu
contribut
impair
protect
immun
follow
hrsv
infect
howev
studi
requir
studi
influenc
receptor
infect
vivo
hrsvinduc
patholog
well
consequ
dc
mediat
tcell
activ
recent
studi
shown
young
infant
ie
month
old
gener
highli
neutral
antibodi
respons
bias
postfus
prefus
form
hrsv
f
protein
howev
children
becom
older
ie
month
old
month
old
respons
redirect
postfus
conform
antigen
goodwin
et
al
thu
antibodi
gener
display
weak
neutral
capac
fail
prevent
hrsv
infect
therefor
possibl
gener
pool
lowneutr
figur
propos
mechan
explain
enhanc
hrsvinduc
diseas
follow
fihrsv
vaccin
formalin
hrsv
inactiv
produc
noninfecti
viru
high
proport
postfus
conform
epitop
f
protein
postf
inactiv
viru
phagocyt
b
cell
present
hrsv
antigen
cell
context
mhc
molecul
interact
b
cell
allow
differenti
b
cell
plasma
cell
gener
antibodi
postfus
conform
hrsv
f
protein
antibodi
fail
neutral
hrsv
infect
also
may
enhanc
infect
bear
cell
dc
infect
hrsv
occur
low
neutral
antibodi
induc
fihrsv
vaccin
form
immunecomplex
ic
hrsv
lead
activ
fcgamma
receptor
express
surfac
dc
subsequ
impair
dcmediat
cell
activ
induc
cell
phenotyp
promot
lung
damag
furthermor
low
secret
cell
activ
hrsvicload
dc
lead
poor
memori
respons
contribut
hrsv
reinfect
antibodi
infanc
facilit
infect
immun
cell
express
phenomenon
call
ade
infect
observ
virus
dengu
viru
flips
et
al
acut
respiratori
syndrom
coronaviru
yip
et
al
porcin
reproduct
respiratori
syndrom
viru
infect
gu
et
al
context
antibodi
might
exert
differ
effector
function
fc
region
hrsv
ade
infect
effect
report
vitro
studi
gimenez
et
al
krilov
et
al
osiowi
et
al
howev
role
ade
hrsv
pathogenesi
vivo
propos
remain
confirm
reinfect
date
vitro
enhanc
infect
monocytederiv
cell
line
due
bind
mab
patient
sera
report
gimenez
et
al
krilov
et
al
osiowi
et
al
demonstr
nonneutr
mab
enhanc
infect
phagocyt
cell
line
express
receptor
gimenez
et
al
neutral
antibodi
appli
subneutr
concentr
ie
dilut
induc
ade
phagocyt
cell
bear
also
observ
use
human
sera
purifi
human
immunoglobulin
ivig
van
erp
et
al
togeth
result
suggest
interact
hrsvic
gener
low
neutral
antibodi
promot
infect
immun
cell
vitro
therefor
contribut
hrsv
pathogenesi
physiolog
condit
administr
formalininactiv
hrsv
vaccin
children
nearli
year
ago
aim
prevent
sever
respiratori
diseas
elicit
hrsv
infect
unabl
produc
protect
immun
hrsv
contrarili
expect
administr
result
increas
morbid
mortal
vaccin
infant
later
infect
viru
kim
et
al
although
mechan
underli
patholog
effect
firsv
vaccin
total
elucid
episod
reveal
complex
associ
vaccin
develop
hamper
rais
hypothesi
patholog
role
hrsvic
kim
et
al
polack
et
al
delgado
et
al
enhanc
hrsv
diseas
erd
firsv
immun
balbc
mice
associ
alveolar
deposit
ic
observ
dpi
hrsv
mean
coloc
igg
complement
compon
protein
role
complement
fix
ic
erd
support
experi
mice
show
significantli
less
airway
hyperrespons
ahr
comparison
wt
counterpart
fihrsv
vaccin
hrsv
challeng
argu
role
complement
bronchoconstrict
observ
erd
polack
et
al
experiment
studi
support
histolog
analysi
lung
section
two
infant
suffer
fatal
erd
icmedi
complement
activ
observ
extens
peribronchiolar
complement
compon
deposit
airway
tissu
polack
et
al
furthermor
suboptim
nonprotect
antibodi
respons
mice
character
high
level
nonneutr
antif
antig
igg
antibodi
observ
immun
fihrsv
infecti
hrsv
polack
et
al
lack
affin
matur
ab
elicit
fihrsv
associ
enhanc
lung
histopatholog
ahr
wherea
supplement
tolllik
receptor
tlr
agonist
perform
immun
promot
proper
affin
matur
prevent
erd
hrsv
challeng
show
defici
tlr
stimul
b
cell
like
respons
lack
ab
affin
matur
fihrsv
vaccin
delgado
et
al
furthermor
cotton
rat
vaccin
firsv
elicit
high
level
hrsvspecif
antibodi
display
low
neutral
titer
vero
cell
piedra
et
al
antibodi
also
abl
caus
ade
vitro
assay
studi
suggest
suboptim
antibodi
product
gener
ic
play
role
erd
develop
figur
furthermor
recent
studi
suggest
subset
immun
respons
key
ahr
erd
knudson
et
al
context
tam
axl
mertk
receptor
express
variou
cell
tissu
ligand
growth
arrestspecif
could
involv
product
immun
respons
reduc
product
type
subclass
antibodi
shibata
ato
antibodi
could
effect
neutral
capac
hrsv
therefor
prevent
hrsv
induc
diseas
product
lower
consequ
fihrsv
immun
follow
hrsv
infect
therefor
possibl
signal
axi
contribut
gener
low
neutral
antibodi
fail
neutral
hrsv
infect
instead
contribut
patholog
caus
hrsv
infect
engag
hrsv
lead
caus
respiratori
ill
infant
major
health
burden
worldwid
reinfect
viru
common
contribut
addit
clinic
manifest
asthma
allergi
reason
sever
studi
focus
understand
mechan
contribut
hrsv
induc
patholog
also
elucid
factor
contribut
reinfect
episod
throughout
life
context
studi
suggest
low
number
memori
hrsvspecif
cell
could
associ
reinfect
episod
level
cell
could
regul
virusspecif
antibodi
modul
function
antigen
present
cell
dc
furthermor
recent
studi
suggest
gener
regulatori
memori
cell
could
impair
interact
hrsvic
dc
point
phenomena
interest
research
topic
deserv
analysi
review
base
sever
studi
discuss
role
hrsv
infect
immunemodulatori
properti
account
recurr
hrsv
infect
episod
enhanc
diseas
caus
fihrsv
vaccin
howev
research
need
understand
hrsv
induc
product
antibodi
fail
prevent
reinfect
knowledg
mechan
would
certainli
appreci
vaccin
therapi
develop
hrsv
repres
major
global
health
problem
oa
fd
respons
write
review
articl
tb
fb
jev
js
pg
review
manuscript
ak
lead
investig
assist
organ
revis
articl
author
list
approv
version
publish
made
substanti
intellectu
contribut
work
work
support
nacion
de
conicyt
programa
de
capit
humano
avanzadobeca
de
doctorado
en
chile
n
n
fondecyt
n
ak
helen
c
levitt
visit
professor
depart
microbiolog
immunolog
univers
iowa
programa
semillero
de
dgi
universidad
de
antofagasta
grant
n
millennium
institut
immunolog
immunotherapi
